Wilmington, Delaware, United States, Sept. 07, 2022 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - An in-depth analysis of women’s health diagnostics market finds prospects of growth of diagnostic laboratory testing and infectious disease testing is attracting companies to tap into opportunities in these segments. High risks associated with transmission of infectious diseases to pregnant women has necessitated the effective diagnosis of various infections. This demonstrates market demand for women’s health diagnostics to improve laboratory testing solutions for improved patient outcomes. The women’s health diagnostics market is estimated to advance at a CAGR of 6% during the forecast period from 2019 to 2027.
Need to serve the increasing demand for point-of-care (POC) treatment for women is leading companies to introduce novel testing options. However, challenges of poor supply chain management and limited availability of POC diagnostic test kits in developing countries pose challenge for manufacturing companies. To this end, companies in the women’s health diagnostics market need to adopt inventory management to ensure accessibility and sustainability of POC testing in limited resource regions, finds a recent women’s health diagnostics market forecast.
Get Exclusive PDF Sample Copy of Women’s Health Diagnostics Market Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=63339
Women’s Health Diagnostics Market – Key Findings of the Report
- Kits & reagents device type segment held a key share of women’s health diagnostics market in 2018, due to their use in cancer biopsy testing, prenatal genetic testing, and infectious disease testing.
- Infectious disease testing segment held the leading share of women’s health diagnostics market in 2018 due to high incidence of infectious diseases in women. However, cervical cancer testing segment is estimated to garner promising revenue among other key test type segments. Development of new tests for early detection of human papillomavirus (HPV) to prevent complications associated with cervical cancer creates enormous opportunities in the segment. Additionally, companies are introducing new type of tests to determine the HPV variant that may lead to cancers in women.
- Diagnostic laboratories & imaging centers held a significant share of women’s health diagnostics market in 2018. Demand for optimization of combined dual HIV/ syphilis testing for cost-effective testing is compelling innovations in the diagnostic labs end user segment. The collaboration of a smartphone diagnostics provider with Columbia University for integration of smartphone-linked blood test for combined HIV/syphilis test is a case in point.
- Asia Pacific holds the third-leading revenue in the women’s health diagnostics market. Companies in the women’s health diagnostics market are engaging in inorganic growth strategies such as M&As to offer healthcare solutions tailored for Asian women. Furthermore, collaborations between companies to offer improved treatment options benefits the women’s health diagnostics market in the region.
- Increasing evidence of successful patient outcomes, to detect severe forms of HPV infections, and to evaluate precancerous markers, is leading to increasing R&D of ‘two-for-one’ diagnostic approach. Serving to be a low-cost alternative to detect the riskiest forms of HPV infection, companies are collaborating with research labs for development of ‘two-for-one’ approach that avoids unnecessary diagnostic procedures, and improves patient outcomes.
Ask for References – https://www.transparencymarketresearch.com/sample/sample.php?flag=ARF&rep_id=63339
Women’s Health Diagnostics Market – Growth Drivers
- Availability of increased laboratory testing options for the increasing diseases in women is fueling the growth of women’s health diagnostics market
- Key role of companies to offer laboratory testing solutions for TORCH infections creates opportunities in women’s health diagnostics market
Women’s Health Diagnostics Market – Key Players
Some of the key players operating in the women’s health diagnostics market are;
- Abbott Laboratories
- bioMerieux SA
- Becton Dickinson and Company
- F. Hoffmann-La Roche AG
- GE Healthcare
- Hologic Inc.
- Koninklijke Philips N.V.
- Quest Diagnostics Inc.
- Siemens AG
- Cardinal Health
Make an Enquiry Before Buying – https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=63339
The women’s health diagnostics market is segmented as follows;
Women’s Health Diagnostics Market, by Device Type
- Biopsy Devices
- Imaging & Monitoring System
- Ultrasound Devices
- Mammography Systems
- MRI Systems
- Others
- Kits & Reagents
- Consumable & Accessories
Women’s Health Diagnostics Market, by Test Type
- Breast Cancer Testing
- Cervical Cancer Testing
- Prenatal Genetic Screening & Carrier Testing
- Pregnancy Testing
- Fertility & Ovulation Testing
- Infectious Disease Testing
- Others
Women’s Health Diagnostics Market, by End User
- Hospitals
- Diagnostic Laboratories & Imaging Centers
- Specialty Clinics
- Others
Women’s Health Diagnostics Market, by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Modernization of healthcare in terms of both infrastructure and services have pushed the healthcare industry to new heights, Stay Updated with Latest Healthcare Research Reports by Transparency Market Research:
Anti-aging Market: The global anti-aging market for anti-wrinkle products was valued at US$ 8,400.0 Mn in 2018 and is projected to expand at a CAGR of 6.0% from 2019 to 2027.
Red Biotechnology Market: The global red biotechnology market is anticipated to reach more than US$ 609.6 Bn by the end of 2031.
Equine Supplement Products Market: The global equine supplement products market is anticipated to reach US$ 111 Mn by the end of 2031. The global market is projected to grow at a CAGR of 3.7% from 2022 to 2031.
Skincare Serum Market: The global skincare serum market is anticipated to reach more than US$ 6.28 Bn by the end of 2031 with a CAGR of 7.4% from 2022 to 2031.
Epilepsy Therapeutics Market: The global epilepsy therapeutics market is anticipated to reach more than US$ 14.9 Bn by the end of 2031.
Smart Insulin Pens Market: The global smart insulin pens market size is prognosticated to expand at notable pace and reach a value of US$ 90.1 Mn by the end of 2031.
Vitamin D Testing Market: The global vitamin D testing market is anticipated to reach more than US$ 1.06 Bn by the end of 2031 with a CAGR of 5.8 % from 2022 to 2031.
Laboratory Gas Generators Market: The global laboratory gas generators market is anticipated to reach more than US$ 1.27 Bn by the end of 2031 with a CAGR of 11.0% from 2022 to 2031.
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ
Contact
Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com
